aluates Reports

$ 0.0

Automative

Global HIV Antiretroviral Therapy Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-3C13243

Global HIV Antiretroviral Therapy Market Research Report 2023

BUY CHAPTERS

Global HIV Antiretroviral Therapy Market Research Report 2025

Code: QYRE-Auto-3C13243

Report

May 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gilead

Roche

ViiV Healthcare

Boehringer Ingelheim

Johnson and Johnson

Mylan NV

Bionor Pharma

Vertex Pharmaceuticals

Merck

Cipla Ltd

AbbVie

HIV Antiretroviral Therapy Market Size

The global market for HIV Antiretroviral Therapy was valued at US$ 3902 million in the year 2024 and is projected to reach a revised size of US$ 5287 million by 2031, growing at a CAGR of 4.5% during the forecast period.

HIV Antiretroviral Therapy Market

Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs. The standard treatment consists of a combination of drugs (often called "highly active antiretroviral therapy" or HAART) that suppress HIV replication.

North American market for HIV Antiretroviral Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for HIV Antiretroviral Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for HIV Antiretroviral Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of HIV Antiretroviral Therapy include Gilead, Roche, ViiV Healthcare, Boehringer Ingelheim, Johnson and Johnson, Mylan, Bionor Pharma, Vertex Pharmaceuticals, Merck, CIPLA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for HIV Antiretroviral Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Antiretroviral Therapy.

The HIV Antiretroviral Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HIV Antiretroviral Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV Antiretroviral Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HIV Antiretroviral Therapy Market Report

Report Metric	Details
Report Name	HIV Antiretroviral Therapy Market
Accounted market size in year	US$ 3902 million
Forecasted market size in 2031	US$ 5287 million
CAGR	4.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nucleoside Reverse Transcriptase Inhibitors (NRTI) Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Protease Inhibitor (PI)
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gilead, Roche, ViiV Healthcare, Boehringer Ingelheim, Johnson and Johnson, Mylan, Bionor Pharma, Vertex Pharmaceuticals, Merck, CIPLA, AbbVie
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV Antiretroviral Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is HIV Antiretroviral Therapy Market growing?

Ans: The HIV Antiretroviral Therapy Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the HIV Antiretroviral Therapy Market size in 2031?

Ans: The HIV Antiretroviral Therapy Market size in 2031 will be US$ 5287 million.

Who are the main players in the HIV Antiretroviral Therapy Market report?

Ans: The main players in the HIV Antiretroviral Therapy Market are Gilead, Roche, ViiV Healthcare, Boehringer Ingelheim, Johnson and Johnson, Mylan, Bionor Pharma, Vertex Pharmaceuticals, Merck, CIPLA, AbbVie

What are the Application segmentation covered in the HIV Antiretroviral Therapy Market report?

Ans: The Applications covered in the HIV Antiretroviral Therapy Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the HIV Antiretroviral Therapy Market report?

Ans: The Types covered in the HIV Antiretroviral Therapy Market report are Nucleoside Reverse Transcriptase Inhibitors (NRTI), Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), Protease Inhibitor (PI)

Recommended Reports

HIV & Antiviral Drugs

Cell & Gene Therapy

Infectious Disease Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV Antiretroviral Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nucleoside Reverse Transcriptase Inhibitors (NRTI)

1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

1.2.4 Protease Inhibitor (PI)

1.3 Market by Application

1.3.1 Global HIV Antiretroviral Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HIV Antiretroviral Therapy Market Perspective (2020-2031)

2.2 Global HIV Antiretroviral Therapy Growth Trends by Region

2.2.1 Global HIV Antiretroviral Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HIV Antiretroviral Therapy Historic Market Size by Region (2020-2025)

2.2.3 HIV Antiretroviral Therapy Forecasted Market Size by Region (2026-2031)

2.3 HIV Antiretroviral Therapy Market Dynamics

2.3.1 HIV Antiretroviral Therapy Industry Trends

2.3.2 HIV Antiretroviral Therapy Market Drivers

2.3.3 HIV Antiretroviral Therapy Market Challenges

2.3.4 HIV Antiretroviral Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HIV Antiretroviral Therapy Players by Revenue

3.1.1 Global Top HIV Antiretroviral Therapy Players by Revenue (2020-2025)

3.1.2 Global HIV Antiretroviral Therapy Revenue Market Share by Players (2020-2025)

3.2 Global HIV Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HIV Antiretroviral Therapy Revenue

3.4 Global HIV Antiretroviral Therapy Market Concentration Ratio

3.4.1 Global HIV Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV Antiretroviral Therapy Revenue in 2024

3.5 Global Key Players of HIV Antiretroviral Therapy Head office and Area Served

3.6 Global Key Players of HIV Antiretroviral Therapy, Product and Application

3.7 Global Key Players of HIV Antiretroviral Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Antiretroviral Therapy Breakdown Data by Type

4.1 Global HIV Antiretroviral Therapy Historic Market Size by Type (2020-2025)

4.2 Global HIV Antiretroviral Therapy Forecasted Market Size by Type (2026-2031)

5 HIV Antiretroviral Therapy Breakdown Data by Application

5.1 Global HIV Antiretroviral Therapy Historic Market Size by Application (2020-2025)

5.2 Global HIV Antiretroviral Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HIV Antiretroviral Therapy Market Size (2020-2031)

6.2 North America HIV Antiretroviral Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HIV Antiretroviral Therapy Market Size by Country (2020-2025)

6.4 North America HIV Antiretroviral Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HIV Antiretroviral Therapy Market Size (2020-2031)

7.2 Europe HIV Antiretroviral Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HIV Antiretroviral Therapy Market Size by Country (2020-2025)

7.4 Europe HIV Antiretroviral Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HIV Antiretroviral Therapy Market Size (2020-2031)

8.2 Asia-Pacific HIV Antiretroviral Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HIV Antiretroviral Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific HIV Antiretroviral Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HIV Antiretroviral Therapy Market Size (2020-2031)

9.2 Latin America HIV Antiretroviral Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HIV Antiretroviral Therapy Market Size by Country (2020-2025)

9.4 Latin America HIV Antiretroviral Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HIV Antiretroviral Therapy Market Size (2020-2031)

10.2 Middle East & Africa HIV Antiretroviral Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HIV Antiretroviral Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa HIV Antiretroviral Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Gilead

11.1.1 Gilead Company Details

11.1.2 Gilead Business Overview

11.1.3 Gilead HIV Antiretroviral Therapy Introduction

11.1.4 Gilead Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.1.5 Gilead Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche HIV Antiretroviral Therapy Introduction

11.2.4 Roche Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.2.5 Roche Recent Development

11.3 ViiV Healthcare

11.3.1 ViiV Healthcare Company Details

11.3.2 ViiV Healthcare Business Overview

11.3.3 ViiV Healthcare HIV Antiretroviral Therapy Introduction

11.3.4 ViiV Healthcare Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.3.5 ViiV Healthcare Recent Development

11.4 Boehringer Ingelheim

11.4.1 Boehringer Ingelheim Company Details

11.4.2 Boehringer Ingelheim Business Overview

11.4.3 Boehringer Ingelheim HIV Antiretroviral Therapy Introduction

11.4.4 Boehringer Ingelheim Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.4.5 Boehringer Ingelheim Recent Development

11.5 Johnson and Johnson

11.5.1 Johnson and Johnson Company Details

11.5.2 Johnson and Johnson Business Overview

11.5.3 Johnson and Johnson HIV Antiretroviral Therapy Introduction

11.5.4 Johnson and Johnson Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.5.5 Johnson and Johnson Recent Development

11.6 Mylan

11.6.1 Mylan Company Details

11.6.2 Mylan Business Overview

11.6.3 Mylan HIV Antiretroviral Therapy Introduction

11.6.4 Mylan Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.6.5 Mylan Recent Development

11.7 Bionor Pharma

11.7.1 Bionor Pharma Company Details

11.7.2 Bionor Pharma Business Overview

11.7.3 Bionor Pharma HIV Antiretroviral Therapy Introduction

11.7.4 Bionor Pharma Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.7.5 Bionor Pharma Recent Development

11.8 Vertex Pharmaceuticals

11.8.1 Vertex Pharmaceuticals Company Details

11.8.2 Vertex Pharmaceuticals Business Overview

11.8.3 Vertex Pharmaceuticals HIV Antiretroviral Therapy Introduction

11.8.4 Vertex Pharmaceuticals Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.8.5 Vertex Pharmaceuticals Recent Development

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck HIV Antiretroviral Therapy Introduction

11.9.4 Merck Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.9.5 Merck Recent Development

11.10 CIPLA

11.10.1 CIPLA Company Details

11.10.2 CIPLA Business Overview

11.10.3 CIPLA HIV Antiretroviral Therapy Introduction

11.10.4 CIPLA Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.10.5 CIPLA Recent Development

11.11 AbbVie

11.11.1 AbbVie Company Details

11.11.2 AbbVie Business Overview

11.11.3 AbbVie HIV Antiretroviral Therapy Introduction

11.11.4 AbbVie Revenue in HIV Antiretroviral Therapy Business (2020-2025)

11.11.5 AbbVie Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gilead

Roche

ViiV Healthcare

Boehringer Ingelheim

Johnson and Johnson

Mylan NV

Bionor Pharma

Vertex Pharmaceuticals

Merck

Cipla Ltd

AbbVie

List of Tables

Table 1. Global HIV Antiretroviral Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nucleoside Reverse Transcriptase Inhibitors (NRTI)

Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Table 4. Key Players of Protease Inhibitor (PI)

Table 5. Global HIV Antiretroviral Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global HIV Antiretroviral Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global HIV Antiretroviral Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global HIV Antiretroviral Therapy Market Share by Region (2020-2025)

Table 9. Global HIV Antiretroviral Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global HIV Antiretroviral Therapy Market Share by Region (2026-2031)

Table 11. HIV Antiretroviral Therapy Market Trends

Table 12. HIV Antiretroviral Therapy Market Drivers

Table 13. HIV Antiretroviral Therapy Market Challenges

Table 14. HIV Antiretroviral Therapy Market Restraints

Table 15. Global HIV Antiretroviral Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global HIV Antiretroviral Therapy Market Share by Players (2020-2025)

Table 17. Global Top HIV Antiretroviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Antiretroviral Therapy as of 2024)

Table 18. Ranking of Global Top HIV Antiretroviral Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by HIV Antiretroviral Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of HIV Antiretroviral Therapy, Headquarters and Area Served

Table 21. Global Key Players of HIV Antiretroviral Therapy, Product and Application

Table 22. Global Key Players of HIV Antiretroviral Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global HIV Antiretroviral Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global HIV Antiretroviral Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global HIV Antiretroviral Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global HIV Antiretroviral Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global HIV Antiretroviral Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global HIV Antiretroviral Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global HIV Antiretroviral Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global HIV Antiretroviral Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America HIV Antiretroviral Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America HIV Antiretroviral Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America HIV Antiretroviral Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe HIV Antiretroviral Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe HIV Antiretroviral Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe HIV Antiretroviral Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific HIV Antiretroviral Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific HIV Antiretroviral Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific HIV Antiretroviral Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America HIV Antiretroviral Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America HIV Antiretroviral Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America HIV Antiretroviral Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa HIV Antiretroviral Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa HIV Antiretroviral Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa HIV Antiretroviral Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Gilead Company Details

Table 48. Gilead Business Overview

Table 49. Gilead HIV Antiretroviral Therapy Product

Table 50. Gilead Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 51. Gilead Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche HIV Antiretroviral Therapy Product

Table 55. Roche Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. ViiV Healthcare Company Details

Table 58. ViiV Healthcare Business Overview

Table 59. ViiV Healthcare HIV Antiretroviral Therapy Product

Table 60. ViiV Healthcare Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 61. ViiV Healthcare Recent Development

Table 62. Boehringer Ingelheim Company Details

Table 63. Boehringer Ingelheim Business Overview

Table 64. Boehringer Ingelheim HIV Antiretroviral Therapy Product

Table 65. Boehringer Ingelheim Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 66. Boehringer Ingelheim Recent Development

Table 67. Johnson and Johnson Company Details

Table 68. Johnson and Johnson Business Overview

Table 69. Johnson and Johnson HIV Antiretroviral Therapy Product

Table 70. Johnson and Johnson Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 71. Johnson and Johnson Recent Development

Table 72. Mylan Company Details

Table 73. Mylan Business Overview

Table 74. Mylan HIV Antiretroviral Therapy Product

Table 75. Mylan Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 76. Mylan Recent Development

Table 77. Bionor Pharma Company Details

Table 78. Bionor Pharma Business Overview

Table 79. Bionor Pharma HIV Antiretroviral Therapy Product

Table 80. Bionor Pharma Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 81. Bionor Pharma Recent Development

Table 82. Vertex Pharmaceuticals Company Details

Table 83. Vertex Pharmaceuticals Business Overview

Table 84. Vertex Pharmaceuticals HIV Antiretroviral Therapy Product

Table 85. Vertex Pharmaceuticals Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 86. Vertex Pharmaceuticals Recent Development

Table 87. Merck Company Details

Table 88. Merck Business Overview

Table 89. Merck HIV Antiretroviral Therapy Product

Table 90. Merck Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 91. Merck Recent Development

Table 92. CIPLA Company Details

Table 93. CIPLA Business Overview

Table 94. CIPLA HIV Antiretroviral Therapy Product

Table 95. CIPLA Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 96. CIPLA Recent Development

Table 97. AbbVie Company Details

Table 98. AbbVie Business Overview

Table 99. AbbVie HIV Antiretroviral Therapy Product

Table 100. AbbVie Revenue in HIV Antiretroviral Therapy Business (2020-2025) & (US$ Million)

Table 101. AbbVie Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. HIV Antiretroviral Therapy Picture

Figure 2. Global HIV Antiretroviral Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HIV Antiretroviral Therapy Market Share by Type: 2024 VS 2031

Figure 4. Nucleoside Reverse Transcriptase Inhibitors (NRTI) Features

Figure 5. Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Features

Figure 6. Protease Inhibitor (PI) Features

Figure 7. Global HIV Antiretroviral Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global HIV Antiretroviral Therapy Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. HIV Antiretroviral Therapy Report Years Considered

Figure 13. Global HIV Antiretroviral Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global HIV Antiretroviral Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global HIV Antiretroviral Therapy Market Share by Region: 2024 VS 2031

Figure 16. Global HIV Antiretroviral Therapy Market Share by Players in 2024

Figure 17. Global Top HIV Antiretroviral Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Antiretroviral Therapy as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by HIV Antiretroviral Therapy Revenue in 2024

Figure 19. North America HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America HIV Antiretroviral Therapy Market Share by Country (2020-2031)

Figure 21. United States HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe HIV Antiretroviral Therapy Market Share by Country (2020-2031)

Figure 25. Germany HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific HIV Antiretroviral Therapy Market Share by Region (2020-2031)

Figure 33. China HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America HIV Antiretroviral Therapy Market Share by Country (2020-2031)

Figure 41. Mexico HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa HIV Antiretroviral Therapy Market Share by Country (2020-2031)

Figure 45. Turkey HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE HIV Antiretroviral Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Gilead Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 50. ViiV Healthcare Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 51. Boehringer Ingelheim Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 52. Johnson and Johnson Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 53. Mylan Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 54. Bionor Pharma Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 55. Vertex Pharmaceuticals Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 56. Merck Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 57. CIPLA Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 58. AbbVie Revenue Growth Rate in HIV Antiretroviral Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Drugs for HIV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Highly Active Antiretroviral Therapy HAART Market Research Report 2024

Global Antiretroviral Agent Market Research Report 2024

Stavudine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Anti HIV Drugs Market Research Report 2024

Antiretroviral Protease Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Assisted Reproductive Technologies Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Antiretroviral Drug Market Research Report 2025

Assisted Reproductive Technologies Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injectable HIV Treatment Market Research Report 2024

Antiviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Zidovudine Market Insights Forecast to 2030

Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Therapy Drug Market Research Report 2025

Assistive Reproductive Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Integrase Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acquired Immunodeficiency Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV 1 RT Inhibitors Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions